Vuong Trieu - 25 Aug 2022 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role: CHAIRMAN AND CEO, Director, 10%+ Owner
Signature: /s/ Trieu, Vuong
Issuer symbol: OTLC
Transactions as of: 25 Aug 2022
Net transactions value: +$6,560
Form type: 4
Filing time: 29 Aug 2022, 09:15:14 UTC
Previous filing: 08 Sep 2021
Next filing: 28 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership
transaction	OTLC	Common Stock	Purchase	$6,560	+80,000	+0.09%	$0.0820	90,348,021	25 Aug 2022	Direct
holding	OTLC	Common Stock						16,780,384	25 Aug 2022	By Autotelic, Inc.
holding	OTLC	Common Stock						6,872,529	25 Aug 2022	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 80,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity on August 25, 2022 from the open market at a price of $0.082.